Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/21/22
End: 01/06/23
Due: 01/06/24
Phase: N/A
Priority: Normal
Start: 06/24/20
End: 08/31/23
Due: 08/31/24
Phase: N/A
Priority: Normal
Start: 07/18/24
End: 06/01/25
Due: 06/01/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study to Evaluate the Effect of Pasteurized Akkermansia Muciniphila (pAkk) on Complaints Related to IBS | NCT05348642 | A-Mansia Biotech S.A. | user2@example.com | None | 2022-07-21 | 2023-01-06 | 2024-01-06 | - | - | 2025-07-14 |
| Effect of Pasteurized Akkermansia Muciniphila on Insulin Resistance in Otherwise Healthy Subjects With Dysglycaemia | NCT05114018 | A-Mansia Biotech S.A. | user2@example.com | None | 2020-06-24 | 2023-08-31 | 2024-08-31 | - | - | 2025-07-14 |
| Study to Assess Effects of Postbiotic vs Placebo in Participants With Diarrhea-predominant IBS | NCT06346847 | A-Mansia Biotech S.A. | user2@example.com | None | 2024-07-18 | 2025-06-01 | 2026-06-01 | - | - | 2025-07-14 |